Geneos Wealth Management’s Xilinx Inc XLNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-915
| Closed | -$194K | – | 3069 |
|
|
2021
Q4 | $194K | Sell |
915
-12
| -1% | -$2.37K | 0.01% | 883 |
|
|
2021
Q3 | $140K | Hold |
927
| – | – | 0.01% | 1021 |
|
|
2021
Q2 | $134K | Sell |
927
-190
| -17% | -$24.2K | 0.01% | 1041 |
|
|
2021
Q1 | $142K | Sell |
1,117
-23
| -2% | -$3.07K | ﹤0.01% | 1141 |
|
|
2020
Q4 | $116K | Buy |
1,140
+212
| +23% | +$27.6K | ﹤0.01% | 1072 |
|
|
2020
Q3 | $93K | Sell |
928
-799
| -46% | -$82K | ﹤0.01% | 975 |
|
|
2020
Q2 | $157K | Buy |
1,727
+54
| +3% | +$4.79K | 0.01% | 739 |
|
|
2020
Q1 | $125K | Hold |
1,673
| – | – | 0.01% | 766 |
|
|
2019
Q4 | $164K | Sell |
1,673
-4
| -0.2% | -$376 | 0.01% | 773 |
|
|
2019
Q3 | $160K | Hold |
1,677
| – | – | 0.01% | 728 |
|
|
2019
Q2 | $197K | Hold |
1,677
| – | – | 0.01% | 670 |
|
|
2019
Q1 | $212K | Sell |
1,677
-46
| -3% | -$5.17K | 0.01% | 622 |
|
|
2018
Q4 | $145K | Sell |
1,723
-50
| -3% | -$4.18K | 0.01% | 706 |
|
|
2018
Q3 | $142K | Sell |
1,773
-200
| -10% | -$14.6K | 0.01% | 771 |
|
|
2018
Q2 | $128K | Sell |
1,973
-160
| -8% | -$10.9K | 0.01% | 708 |
|
|
2018
Q1 | $154K | Hold |
2,133
| – | – | 0.01% | 611 |
|
|
2017
Q4 | $143K | Hold |
2,133
| – | – | 0.01% | 633 |
|
|
2017
Q3 | $151K | Sell |
2,133
-73
| -3% | -$4.77K | 0.02% | 594 |
|
|
2017
Q2 | $141K | Hold |
2,206
| – | – | 0.01% | 596 |
|
|
2017
Q1 | $127K | Buy |
2,206
+12
| +0.5% | +$705 | 0.01% | 599 |
|
|
2016
Q4 | $132K | Buy |
2,194
+160
| +8% | +$8.6K | 0.02% | 547 |
|
|
2016
Q3 | $110K | Hold |
2,034
| – | – | 0.01% | 578 |
|
|
2016
Q2 | $93K | Hold |
2,034
| – | – | 0.01% | 612 |
|
|
2016
Q1 | $96K | Buy |
+2,034
| New | +$95.5K | 0.01% | 598 |
|
Other funds holding XLNX
Geneos Wealth Management's XLNX Position: Q1 2022 in Review
Geneos Wealth Management sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 915 shares — an estimated $194K sold.
Geneos Wealth Management first reported a position in XLNX in Q1 2016 and held it in 24 quarters. The position peaked at $212K in Q1 2019. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.
- Geneos Wealth Management reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
- Geneos Wealth Management sold 915 Xilinx Inc shares in Q1 2022, an estimated $194K.
- Geneos Wealth Management first reported a position in Xilinx Inc in Q1 2016 and held it in 24 quarters.
- Geneos Wealth Management's Xilinx Inc position peaked at $212K in Q1 2019.
- 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.
Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.